News
Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure.
A multidisciplinary prehabilitation protocol shows promise in reversing frailty and improving outcomes for patients with ...
"We are thrilled to see the C-MIC II results published in the European Journal of Heart Failure ," said John Brumfield, CEO of Berlin Heals "These findings support our mission to develop breakthrough, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results